Cutaneous Hydration Assessment in SCD
Cutaneous Hydration Assessment in Sickle Cell Disease
Race/ethnicity-specific condition
Phase
NA
Enrollment
30 (est.)
Age range
12 Years to —
Sex
ALL
Summary
This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).
Conditions studied
Sickle Cell Disease
Sign-up window
Jan 21, 2022 – est. completion Dec 31, 2026
Sponsors
Enrico NovelliLead
Study locations
UPMC Sickle Cell Clinic
Pittsburgh, Pennsylvania
Enrico Novelli, MD, CONTACT